AzTrials
AzTrials

Postoperative PainNCT04681222

Comparison of the Efficacy of PENG Block in Combination With LFCN Block and Wound Infiltration

An observational study of Postoperative Pain, run by Derince Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The ultrasound-guided approach for the blockade of articular branches of femoral and obturator nerves, pericapsular nerve group (PENG) block, is an effective method for postoperative analgesia in hip surgeries. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Pain
What is being tested?
LFCN and Wound infiltration
Type of treatment
Surgery or procedure
How many people
22 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2019to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients underwent total hip arthroplasty with the diagnosis of coxarthrosis, and those received PENG blocks for postoperative analgesia combined with whether LFCN block or wound infiltration.

Who may be able to join

  • Coxarthrosis
  • Total hip replacement
  • Patients agreed to receive PENG block
  • LFCN or wound infiltration performed combined with PENG blocks

Who cannot join

  • Other kinds of hip surgeries
  • Total hip replacement performed for other indications
  • Patients refused to receive PENG block

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Derince Training and Research Hospital

    Kocaeli, Derince, 41900

Other trials in Turkey (Türkiye)

About this study

Official title: Postoperative Pain Management in Patients Undergoing Total Hip Arthroplasty: PENG Block in Combination With LFCN Block or Wound Infiltration?

The ultrasound-guided approach for the blockade of articular branches of femoral and obturator nerves, pericapsular nerve group (PENG) block, is an effective method for postoperative analgesia in hip surgeries.

Read the detailed description

The ultrasound-guided approach for the blockade of articular branches of femoral and obturator nerves, pericapsular nerve group (PENG) block, is an effective method for postoperative analgesia in hip surgeries. However, it fails to provide cutaneous analgesia on the anterolateral surgical incisional site. This study compares the effects of wound infiltration and lateral femoral nerve blocks in combination with PENG blocks for postoperative pain in patients undergoing total hip arthroplasty for coxarthrosis.

Being tested
LFCN, Wound infiltration
Keywords
Coxarthrosis, Regional Anesthesia, Total Hip Replacement
Medical subject headings
Pain, Postoperative, Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LFCNProcedure or surgery

    LFCN block was performed in combination with PENG block

  • Wound infiltrationProcedure or surgery

    Wound infiltration was performed in combination with PENG block

Study groups in NCT04681222
Study groupRoleWhat they receive
LFCNPatients received LFCN + PENG blocks
Receives: Procedure: LFCN
Wound InfiltrationPatients received wound infiltration + PENG blocks
Receives: Procedure: Wound infiltration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First analgesic demand

    The time interval from PENG blocks to the first analgesic demand.

    Measured: 24 hours

Secondary outcomes (3)
  1. Opioid consumption

    Total opioid analgesic consumption

    Measured: 24 hours

  2. Numeric Rating Scale

    The maximum score on a 10cm numeric rating scale: (0 to 10cm) (0 = no pain, 10 = worst imaginable pain)

    Measured: 24 hours

  3. Nonsteroidal Anti-inflammatory Drugs (NSAID)

    Total NSAID consumption

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2020
  2. Study start1 Jan 2019
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04681222
Sponsor's protocol ID
U1111-1262-9877
Status last verified
Dec 2020
First submitted
18 Dec 2020
Last updated
24 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.

    PubMed 30063657
  • Roy R, Agarwal G, Pradhan C, Kuanar D. Total postoperative analgesia for hip surgeries, PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28:rapm-2019-100454. doi: 10.1136/rapm-2019-100454. Online ahead of print. No abstract available.

    PubMed 30923252
  • Nersesjan M, Hagi-Pedersen D, Andersen JH, Mathiesen O, Dahl JB, Broeng L, Thybo KH. Sensory distribution of the lateral femoral cutaneous nerve block - a randomised, blinded trial. Acta Anaesthesiol Scand. 2018 Jul;62(6):863-873. doi: 10.1111/aas.13091. Epub 2018 Feb 21.

    PubMed 29468642
  • Giron-Arango L, Roques V, Peng P. Reply To Dr Roy et al: Total postoperative analgesia for hip surgeries: PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28:rapm-2019-100505. doi: 10.1136/rapm-2019-100505. Online ahead of print. No abstract available.

    PubMed 30923249
  • Mistry T, Sonawane KB, Kuppusamy E. PENG block: points to ponder. Reg Anesth Pain Med. 2019 Mar;44(3):423-424. doi: 10.1136/rapm-2018-100327. Epub 2019 Jan 11. No abstract available.

    PubMed 30635514

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Pain, run by Derince Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First analgesic demand (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04681222, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in